Pregnant women are at higher risk of severe COVID-19, and their risk of going into intensive care is higher than non-pregnant women with COVID-19.
Dr Vicki Smith has been awarded £470,000 to explore the regulation of cell movement, looking at preventing and treating life-threatening conditions.
People who stop smoking may experience improvements in their mental health such as reductions in anxiety and depression symptoms, finds research carried out in collaboration with the University of Birmingham.
Women with polycystic ovary syndrome (PCOS) are at a significantly increased risk of contracting COVID-19 than women without the condition, new research led by the University of Birmingham has revealed.
New research has been launched to look at the possible re-purposing of selective P2X7 receptor blocker drugs to treat patients with secondary brain damage.
A maternity triage system developed by clinicians and researchers from the West Midlands has launched training online for the first time, becoming readily available to maternity teams across the UK.
University Hospitals Birmingham's brain tumour centre has been recognised as a Tessa Jowell Centre of Excellence following rigorous expert-led assessments by the Tessa Jowell Brain Cancer Mission.
A UK study sponsored and run by the University of Birmingham has launched aiming to better understand the immune response to COVID-19 vaccinations in patients with certain immunosuppressed conditions including cancer.
International travellers are at risk to virulent strains of drug-resistant bacteria – often picking up several different types during a trip via other tourists.
A study led by the University of Birmingham has found combining advanced imaging and artificial intelligence techniques can accurately classify the characteristics of common types of childhood brain tumours.
The University today launches a major £2.2m government-funded research project to improve the treatment of so-called Long COVID in non-hospitalised patients.
Alice's Arc have generously supported a new Birmingham research project looking at improving treatment for children with fusion-negative rhabdomyosarcoma (RMS).